医用大麻项目中慢性疼痛成人使用大麻与患者报告疼痛结局的关联
该横断面研究纳入2022年3-4月美国36个州及DC有活跃医用大麻项目的1628名慢性非癌痛成人,评估大麻使用与患者报告疼痛指标的关系。结果显示,过去30天内使用大麻者相比从未使用者报告更高的疼痛强度和干扰评分,但差异无临床意义,且疼痛负担更重者更可能使用大麻。
要点
- 活动性大麻使用与更高的疼痛强度和干扰评分相关,但差异未达临床意义。
- 活动性使用者的广泛疼痛指数更高且慢性疼痛诊断数量更多。
- 疼痛更重和负担更大的患者可能更倾向于使用大麻。
核心结论
- 使用大麻治疗慢性非癌痛的患者报告了非临床意义的更差疼痛指标和更大的慢性疼痛负担,反之疼痛更重者更可能使用大麻。
研究设计与样本
- 横断面研究,纳入2022年3月至4月美国36个州及DC有活跃医用大麻项目的1628名慢性非癌痛成人代表性样本。
- 大麻使用分为活动性(30天内)、过去(>31天)和从未使用(参照组)。
- 主要结局为疼痛强度,次要结局包括疼痛干扰、广泛疼痛指数和慢性疼痛诊断数量。
主要发现
- 1628名参与者中,352人(22%)活动性使用大麻治疗慢性疼痛,137人(8%)过去使用,1139人(70%)从未使用。
- 调整模型中,活动性使用与更高疼痛强度评分相关(评分差1.03,95%CI 0.05至2.02)和更高疼痛干扰评分相关(评分差1.82,95%CI 0.99至2.65),相比从未使用。
- 活动性使用者广泛疼痛指数评分更高(评分差0.56,95%CI 0.26至0.86)且慢性疼痛诊断数量更多(差值0.45,95%CI 0.06至0.83)。
临床怎么用
- 临床评估慢性疼痛患者时应询问大麻使用情况,但需注意大麻使用与更差疼痛指标相关而非改善。
- 对于疼痛负担更重的患者,应关注其可能使用大麻并综合管理疼痛。
局限性
- 横断面设计无法确定因果关系,反向因果可能解释部分关联。
- 样本仅来自有活跃医用大麻项目的州,外推性受限。
- 大麻使用自我报告可能存在测量偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Most Americans live in a state that has legalized cannabis as a medical treatment for pain, but it is unclear how chronic pain intensity relates to cannabis use. Our objective was to examine the association between patient-reported pain measures and cannabis among adults with chronic pain. METHODS: This cross-sectional study of a representative sample of adults reporting chronic non-cancer pain in 36 states and DC with active medical cannabis programs from March to April 2022 assessed cannabis use for chronic pain, categorized as active (within 30 days), past (>31 days), or never use (referent). Measures were pain intensity (primary) and interference, Widespread Pain Index, and number of chronic pain diagnoses. RESULTS: Among 1628 participants (57% female, 69% white), 352 (22%) actively used cannabis to treat chronic pain, 137 (8%) reported past cannabis use, and 1139 (70%) never used cannabis. In adjusted models, active cannabis use was associated with higher scores for pain intensity (score difference 1.03, 95% CI 0.05 to 2.02) and pain interference (score difference 1.82, 95% CI 0.99 to 2.65) compared with never use. Persons who actively used cannabis had higher Widespread Pain Index scores (score difference 0.56, 95% CI 0.26 to 0.86) and more chronic pain diagnoses (difference 0.45, 95% CI 0.06 to 0.83). CONCLUSION: People with chronic non-cancer pain who used cannabis for pain reported non-clinically meaningful worse pain measures and greater burden of chronic pain conditions than their counterparts who never used cannabis. Alternatively, those with worse pain and greater burden of pain appear more likely to use cannabis.
引用
- Bicket MC, Stone EM, McGinty EB, et al. Association of cannabis use with patient-reported pain measures among adults with chronic pain in US states with medical cannabis programs. Reg Anesth Pain Med. 2024. PMID: 37923347. doi:10.1136/rapm-2023-104833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。